Seval Türkmen Selected Research

Drug Therapy (Chemotherapy)

1/2022

Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seval Türkmen Research Topics

Disease

4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2015
3	Leukemia 01/2022 - 04/2010
3	Multiple Myeloma 08/2014 - 03/2007
2	Aneuploidy (Aneuploid) 01/2019 - 01/2018
2	Philadelphia Chromosome 01/2015 - 04/2010
1	Myocardial Infarction 01/2021
1	Inflammation (Inflammations) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Thrombocytosis (Thrombocythemia) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Monoclonal Gammopathy of Undetermined Significance 08/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2014
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2012
1	type 2 Syndactyly 06/2010
1	Disease Progression 04/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2010
1	Neoplasms (Cancer) 04/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2010
1	Blast Crisis (Blast Phase) 04/2010
1	recessive Cutis laxa 06/2009
1	Dystonia (Limb Dystonia) 05/2009
1	Ataxia (Dyssynergia) 05/2009
1	Paraproteinemias (Monoclonal Gammopathy) 03/2007
1	Sotos Syndrome 11/2003
1	Marfan Syndrome (Marfan's Syndrome) 09/2002

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2014
2	nilotinib FDA Link 01/2015 - 04/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2009 - 03/2007
1	C-Reactive ProteinIBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	PlatinumIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	anagrelide (Agrylin)FDA LinkGeneric 01/2016
1	Biological ProductsIBA 08/2015
1	IgKIBA 08/2014
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 08/2014
1	polyalanineIBA 06/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2010
1	Tyrosine Kinase InhibitorsIBA 04/2010
1	Histone Deacetylase InhibitorsIBA 04/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2010
1	PanobinostatIBA 04/2010
1	Melphalan (Alkeran)FDA LinkGeneric 04/2010
1	Vorinostat FDA Link 04/2010
1	Phosphotransferases (Kinase)IBA 04/2010
1	Imatinib Mesylate (Gleevec)FDA Link 04/2010
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 04/2010
1	Proton-Translocating ATPases (ATPase, H+)IBA 06/2009
1	Inosine Triphosphate (ITP)IBA 05/2009
1	EnzymesIBA 03/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2003
1	Fibrillin-1IBA 09/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2010
2	Stem Cell Transplantation 01/2016 - 04/2010
1	Consolidation Chemotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Ligation 01/2019
1	Salvage Therapy 04/2014